icon-folder.gif   Conference Reports for NATAP  
 
  17th European AIDS Conference
November 6-9
2019, Basel
Back grey_arrow_rt.gif
 
 
 
Sustained Viral Suppression among Participants with Pre-existing M184V/I Who Switched to Bictegravir/Emtricitabine/TenofovirAlafenamide
 
 
  117th European AIDS Conference (EACS), 6-9 November 2019, Basel, Switzerland Reported by Jules Levin
 
Kristen Andreatta, Rima Acosta, Michelle L. D'Antoni, Danielle P. Porter, Silvia Chang, Ross Martin, Madeleine Willkom, Hui Lui, Ian McNicholl, Joel Gallant, Cheryl Pikora, Hiba Graham, Sean Collins, Hal Martin, and Kirsten L. White Gilead Sciences, Foster City, CA, 94404

1112191

1112192

1112193

1112194

1112195

1112196